Latest Market Research Reports

  Inhaled Nitric Oxide Delivery Systems Industry According to a new report by Grand View Research, Inc., the global market for inhaled nitric oxide (INO) delivery systems is projected to reach a valuation of USD 434.2 million by the year 2028. The market is expected to expand at a compound annual growth rate (CAGR) of 6.9% during the forecast period. Several factors are contributing to this growth, including the rising incidence of respiratory failure in neonates, increasing levels of environmental pollution that lead to lung diseases in adults, and the growing need for treatments that offer rapid therapeutic responses with minimal complications. These factors are collectively accelerating the adoption of inhaled nitric oxide therapy across a range of patient populations. Additionally, the market is being positively influenced by the presence of numerous small-scale manufacturers who contribute to increased accessibility and competition, as well as by research initiatives led by ma...

Inhaled Nitric Oxide Delivery Systems Industry Overview The global inhaled nitric oxide delivery systems market size was valued at USD 247.5 million in 2020 and is projected to grow at a compound annual growth rate (CAGR) of 6.9% from 2021 to 2028.  Inhaled Nitric Oxide (INO), a minimally invasive therapy, is proposed to treat conditions associated with reversible pulmonary vasoconstriction and pulmonary hypertension in children and adults. Improved safety and efficacy, a rapid offset of action, reduced toxicity, high concentration of drug at the target organ, avoidance of systemic adverse reaction, and reduced dose of medication are some of the advantages of INO over other medication. This is leading to the improved adoption of INO, potentially driving the market growth. Gather more insights about the market drivers, restrains and growth of the  Global  Inhaled Nitric Oxide Delivery Systems Market In vitro studies suggest that INO is effective in suppressing the SARS...